A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia
about
Bone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated down-regulation of Cdk6Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoterRepression of Runx2 by androgen receptor (AR) in osteoblasts and prostate cancer cells: AR binds Runx2 and abrogates its recruitment to DNACHIP promotes Runx2 degradation and negatively regulates osteoblast differentiationAn important role for RUNX3 in human L1 transcription and retrotranspositionTranscriptional regulatory cascades in Runx2-dependent bone developmentTGF-β signaling in C. elegansTGF-β and BMP signaling in osteoblast differentiation and bone formationA pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturationMolecular and cellular aspects of calcific aortic valve diseaseMutations in the RUNX2 gene in patients with cleidocranial dysplasiaDimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradationBRITER: a BMP responsive osteoblast reporter cell lineThe interferon-inducible p204 protein acts as a transcriptional coactivator of Cbfa1 and enhances osteoblast differentiationBone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cellsBMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expressionParathyroid hormone-Smad3 axis exerts anti-apoptotic action and augments anabolic action of transforming growth factor beta in osteoblastsMitotic partitioning and selective reorganization of tissue-specific transcription factors in progeny cellsCbfbeta interacts with Runx2 and has a critical role in bone developmentFoxo1 mediates insulin-like growth factor 1 (IGF1)/insulin regulation of osteocalcin expression by antagonizing Runx2 in osteoblastsLymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoterNuclear Export of Smads by RanBP3L Regulates Bone Morphogenetic Protein Signaling and Mesenchymal Stem Cell DifferentiationNon-virus-mediated transfer of siRNAs against Runx2 and Smad4 inhibit heterotopic ossification in rats.Tissue-specific calibration of extracellular matrix material properties by transforming growth factor-β and Runx2 in bone is required for hearingThe roles of extracellular signal-regulated kinase 1/2 pathway in regulating osteogenic differentiation of murine preosteoblasts MC3T3-E1 cells on roughened titanium surfaces.Opposite Smad and chicken ovalbumin upstream promoter transcription factor inputs in the regulation of the collagen VII gene promoter by transforming growth factor-beta.Smad signaling in skeletal development and regeneration.Dual roles of smad proteins in the conversion from myoblasts to osteoblastic cells by bone morphogenetic proteins.TIEG1/KLF10 modulates Runx2 expression and activity in osteoblasts.The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts.Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites.Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation.Biological regulation of bone quality.Bone morphogenetic protein-2-induced signaling and osteogenesis is regulated by cell shape, RhoA/ROCK, and cytoskeletal tensionmiR-764-5p promotes osteoblast differentiation through inhibition of CHIP/STUB1 expression.Glutamine repeat variants in human RUNX2 associated with decreased femoral neck BMD, broadband ultrasound attenuation and target gene transactivationExpression pattern, regulation, and biological role of runt domain transcription factor, run, in Caenorhabditis elegansThe novel PIAS-like protein hZimp10 enhances Smad transcriptional activity.The Runt-related transcription factor 1 in prostate cancer-associated fibroblastsThe RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis.
P2860
Q24299331-09E3C969-40B5-4538-9A99-9241E24981F3Q24537942-6238080E-8106-49CB-9E92-D26666F3282FQ24641909-D434D9B1-42D9-4F8A-B892-1D954A5AE170Q24656900-5F3E5DAC-44C6-4C83-B4C1-51BC62B64893Q24670621-792A5D24-E7DA-4F37-ACFD-27C1DD95210CQ26830666-A55B61B9-742D-4E87-8635-7986D0DD4124Q26850420-4A7E8BC6-63C9-4AB8-A94C-BA4690A88F58Q26995720-D1146C78-C5EA-4DFA-A929-F604011F3E3EQ26995910-6AA5591B-BCB7-4269-943D-12D0D5DF36F7Q27026105-C25112A5-30C2-4A26-8284-9D5C94EBB3F2Q28202887-19B9914B-A2F5-47BC-B0F6-403EAE5AEDE9Q28348865-F68679C9-5162-4942-8EA7-A41A9B05DCB6Q28483777-75CEAAC9-7AD7-4FFF-8150-9D043664FBFAQ28506894-AD313AB9-3180-4AA4-91AB-14E2FF0AD97CQ28565698-A7B94BB8-EE34-4402-8E2E-D6788BA4D76EQ28570736-71DFDD22-F3F3-46FC-89AD-9194F701DA54Q28573174-7366E473-7857-4473-B408-ED53E4414F1EQ28573678-D11156CB-BFFB-48E0-955E-A0E3B00615FAQ28586662-D336E2BF-1A5B-4F66-AE45-E5EC5BE7B59EQ28591040-2061CCD3-4F89-4AD5-B5C9-A4FEDA5906CDQ28593503-06F0289E-45DC-4ABC-85BE-14ABAB838C37Q28941240-E409026E-D9AE-4DF6-97A0-6DF11F5BA823Q30273970-A8CD55FC-B454-4A7A-986E-347140EEBB42Q30496822-96593780-CDEA-4CDC-9E41-D3DC5ABD4544Q31035872-B00F344D-C3E5-4ED5-8EB7-C95D22E269E2Q33200353-129DBADA-46C8-4CAC-9A34-E26EFC500288Q33674328-FA7A52C5-AADF-46EC-8DC9-4FEC96E6A77AQ33832595-7454E79A-CC55-4C94-BFF3-751DF0853E6DQ33894869-6E3372BA-DED7-478E-8335-26381EEA05A3Q33953806-184F0A11-519A-4992-A2AF-C92384D5B5DBQ34031066-6687175A-0566-4660-8D27-479F28F51637Q34049104-6AD585CA-4182-4DB7-9856-8FD213D115EFQ34051287-D5C49E29-F30F-4597-B3F9-6762C12DDA6AQ34221060-D7F9346D-6CA2-490C-84B4-B1A3B985E4A0Q34260429-37C89D15-9EB0-4CB2-92AC-BBA54A5DA599Q34388792-27457F62-63F9-46CA-8BDF-D169A4F15B0EQ34440372-57598BF3-BBA5-4E67-86BA-7A607108F751Q34538658-88748C95-A7A2-4F13-B69A-7F3BFC393EA6Q34581047-758E03E1-15B6-4BCF-B732-32892EBDA509Q34718167-3F1D8C12-F2FF-42DC-987B-8862806FCFDF
P2860
A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A RUNX2/PEBP2alpha A/CBFA1 mut ...... ion in cleidocranial dysplasia
@ast
A RUNX2/PEBP2alpha A/CBFA1 mut ...... ion in cleidocranial dysplasia
@en
A RUNX2/PEBP2alpha A/CBFA1 mut ...... ion in cleidocranial dysplasia
@nl
type
label
A RUNX2/PEBP2alpha A/CBFA1 mut ...... ion in cleidocranial dysplasia
@ast
A RUNX2/PEBP2alpha A/CBFA1 mut ...... ion in cleidocranial dysplasia
@en
A RUNX2/PEBP2alpha A/CBFA1 mut ...... ion in cleidocranial dysplasia
@nl
prefLabel
A RUNX2/PEBP2alpha A/CBFA1 mut ...... ion in cleidocranial dysplasia
@ast
A RUNX2/PEBP2alpha A/CBFA1 mut ...... ion in cleidocranial dysplasia
@en
A RUNX2/PEBP2alpha A/CBFA1 mut ...... ion in cleidocranial dysplasia
@nl
P2093
P2860
P356
P1476
A RUNX2/PEBP2alpha A/CBFA1 mut ...... ion in cleidocranial dysplasia
@en
P2093
K Miyazono
P2860
P304
P356
10.1073/PNAS.180309597
P407
P577
2000-09-12T00:00:00Z